These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18800188)

  • 1. Cysteine-rich 61 (CYR61) inhibits cisplatin-induced apoptosis in ovarian carcinoma cells.
    Rho SB; Woo JS; Chun T; Park SY
    Biotechnol Lett; 2009 Jan; 31(1):23-8. PubMed ID: 18800188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyr61 expression influences cancer cell proliferation and apoptosis via PI3K pathway in human ovarian carcinoma cells].
    Xiao L; He C; Li X; Chen Y; Zhou JD
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):616-20. PubMed ID: 23141184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhang F; Chen H; Du J; Wang B; Yang L
    Med Sci Monit; 2018 Sep; 24():6093-6101. PubMed ID: 30171812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
    Bartel F; Balschun K; Gradhand E; Strauss HG; Dittmer J; Hauptmann S
    Int J Gynecol Pathol; 2012 Sep; 31(5):405-15. PubMed ID: 22833079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
    Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
    Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
    Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
    Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoke-induced early growth response-1 regulates the expression of the cysteine-rich 61 in human skin dermal fibroblasts.
    Kim JN; Kim HJ; Jeong SH; Kye YC; Son SW
    Exp Dermatol; 2011 Dec; 20(12):992-7. PubMed ID: 21995436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.
    Jiang L; Luo RY; Yang J; Cheng YX
    Mol Med Rep; 2013 Feb; 7(2):425-30. PubMed ID: 23229441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
    Lin Y; Xu T; Tian G; Cui M
    J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis.
    Xu T; He YH; Wang MQ; Yao HW; Ni MM; Zhang L; Meng XM; Huang C; Ge YX; Li J
    Gene; 2016 Oct; 592(1):179-185. PubMed ID: 27457285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells.
    Lee KB; Byun HJ; Park SH; Park CY; Lee SH; Rho SB
    Cancer Lett; 2012 Feb; 315(1):86-95. PubMed ID: 22078465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
    Chin LH; Hsu SP; Zhong WB; Liang YC
    Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
    Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
    Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1{alpha} and transforming-growth factor-{beta}3 in the human trophoblast.
    Wolf N; Yang W; Dunk CE; Gashaw I; Lye SJ; Ring T; Schmidt M; Winterhager E; Gellhaus A
    Endocrinology; 2010 Jun; 151(6):2835-45. PubMed ID: 20237132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
    Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
    Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1 Promotes Chemoresistance to Cisplatin in Ovarian Cancer Cells by Suppressing SLC3A2.
    Cui Y; Qin L; Tian D; Wang T; Fan L; Zhang P; Wang Z
    Chemotherapy; 2018; 63(5):262-271. PubMed ID: 30481785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
    Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.